Akebia Therapeutics, Inc. IPO Research Information

Akebia Therapeutics, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Akebia Therapeutics, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Akebia Therapeutics, Inc.	AKBA -	Last trade $12.85	$12.00	$0.00	11 million	5/12/2020
Underwriter(s): J.P. Morgan, Piper Sandler
Co-Manager(s): BTIG, Mizuho, H.C. Wainwright
Industry:
Filing(s):

Akebia Therapeutics, Inc. Quote & Chart - Click for current quote - AKBA

About Akebia Therapeutics, Inc. (adapted from Akebia Therapeutics, Inc. prospectus):
Akebia Therapeutics, Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on delivering innovative therapies to patients with kidney disease through hypoxia-inducible factor biology.

This description is adapted from AkebiaTherapeutics-AKBA prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as AkebiaTherapeutics-AKBA "AKBA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.